Guides
14 pages in this section, most recently updated September 4, 2026.
- 01
Semaglutide titration planner: Ozempic, Wegovy and tablet schedules by date
How the planner turns the label escalation schedules for Ozempic, Wegovy, Wegovy tablets, Rybelsus and Ozempic tablets into dated steps, what it refuses to do, and which decisions stay with your prescriber.
Updated September 4, 2026
- 02
Compounded semaglutide units to mg: how the converter works
Why a compounded semaglutide vial needs arithmetic that a brand pen does not, how the converter turns a concentration and a prescribed dose into syringe units and the nearest mark, and the errors it is built to catch.
Updated September 4, 2026
- 03
Missed a semaglutide dose? The label rules for Ozempic, Wegovy and the tablets
The exact missed-dose text from the Ozempic, Wegovy injection and semaglutide tablet labels, why the two injection rules give different answers, and how the helper applies them to your clock.
Updated September 4, 2026
- 04
Semaglutide side effects by the numbers: STEP rates, placebo rates and when they happen
The adverse reaction tables from the Wegovy and Ozempic labels, the pooled STEP 1 to 3 tolerability analysis, and what the trials say about timing, with the arithmetic that turns a percentage into a personal risk.
Updated September 4, 2026
- 05
What semaglutide costs in 2026: NovoCare self-pay prices, dated
Novo Nordisk's published self-pay prices for Wegovy pens, Wegovy HD, Wegovy tablets, Ozempic pens and Ozempic tablets as of the April 2026 price sheet, the introductory offers and their expiry, the insurance and Medicare programs, and how to compare any of it per milligram.
Updated September 4, 2026
- 06
Ozempic dosing schedule: what the label says at each step
The Ozempic escalation from 0.25 mg to 2 mg as the label writes it, the three pens and what each delivers, the glycemic-control decision points, the kidney and cardiovascular indications, and what the label does not say.
Updated September 4, 2026
- 07
Wegovy dosing schedule: 0.25 mg to 2.4 mg, and now 7.2 mg
The Wegovy injection escalation table as the label writes it, the maintenance choices by indication, the 7.2 mg Wegovy HD step approved March 19, 2026, the tablet schedule, the switching rules, and the four indications behind them with dates.
Updated September 4, 2026
- 08
Semaglutide tablets: Rybelsus, Ozempic tablets and the Wegovy pill
Three oral semaglutide products, two formulations, one set of swallowing rules. Doses, escalation, the 30-minute window, approval dates, and the OASIS 4 numbers behind the weight-management pill.
Updated September 4, 2026
- 09
Changing your semaglutide injection day: the 48-hour rule
What the Ozempic and Wegovy labels allow when you want a different weekly day, the two-day minimum between doses, worked examples for moving earlier and later, and how it interacts with a missed dose.
Updated September 4, 2026
- 10
Compounded semaglutide after the shortage: what changed on February 21, 2025 and since
The FDA declaratory order that ended the semaglutide shortage, the 503A and 503B grace periods, what FDA says about dosing errors and salt forms, the adverse event counts, and the questions to ask any pharmacy still dispensing it.
Updated September 4, 2026
- 11
Ozempic and Wegovy pens explained: strengths, concentrations, storage
Why Ozempic has three multi-dose pens and Wegovy has six single-dose ones, what each contains in mg and mL, how long they last out of the fridge, and why none of it translates to syringe units.
Updated September 4, 2026
- 12
The STEP trials by the numbers: what semaglutide 2.4 mg did in each one
STEP 1 through 10 and STEP UP in one table: who was enrolled, how long, weight change on drug and placebo, the treatment difference with its confidence interval, and the tolerability figure each paper reported, with PubMed ids.
Updated September 4, 2026
- 13
Beyond weight: SELECT, SUSTAIN-6 and FLOW, the outcome trials behind the semaglutide labels
The three trials that turned semaglutide from a glucose and weight drug into one with cardiovascular and kidney indications: who was in them, what was counted, the hazard ratios with confidence intervals, and what each label says as a result.
Updated September 4, 2026
- 14
Stopping semaglutide: what STEP 4 measured and what the labels require
The one randomised trial that withdrew semaglutide after people reached 2.4 mg, what happened to weight, waist and blood pressure over the following 48 weeks, the label's washout rules before pregnancy and surgery, and how to restart per the label.
Updated September 4, 2026